Gene: SSX1

6756
CT5.1|SSRC
SSX family member 1
protein-coding
Xp11.23
Ensembl:ENSG00000126752 MIM:312820 Vega:OTTHUMG00000021488 UniprotKB:Q16384
NG_012528.2
PubMed
ND
1   
NA (AD)  NA (ND)   (Frontal_Cortex)
NA (AD)  NA (ND)

DNA Methylation

There is no related methylation information for this gene.

Gene Expression in Different Tissues

Temporal and Spatial Expressions (BrainSpan)

Footnote:
SC: sub-cortical regions; SM: sensory-motor regions; FC: frontal cortex; and TP: temporal-parietal cortex
ST1: fetal (13 - 26 postconception weeks), ST2: early infancy to late childhood (4 months to 11 years), and ST3: adolescence to adulthood (13 - 23 years)
The bar shown representes average value of the expressions.

Top Co-expressed Genes in Brain-Frontal Cortex (BA9) (GTEx v7)

Top 10 positively co-expressed genes

Gene Symbol Pearson Correlation Coefficient
HOXB90.913
PRAME0.906
PAGE50.896
CTCFL0.885
MAGEA60.88
MAGEC20.878
IGF2BP10.876
MAGEA30.864
MAGEB20.86
HBG10.838

Top 10 negatively co-expressed genes

Gene Symbol Pearson Correlation Coefficient
OTOA-0.202
C6orf226-0.201
GRK1-0.192
FAM86C1-0.192
ABHD16B-0.187
ARSF-0.184
LCMT2-0.18
GPR3-0.178
LRRC29-0.178
SPATA2L-0.177

Drugs/Compounds

    There is no DrugBank record for this gene !

ID Drug Name Action PubMed
C4591794-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide"[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SSX1 mRNA"27188386
C516138(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine"[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SSX1 mRNA"27188386
D000082AcetaminophenAcetaminophen results in decreased expression of SSX1 mRNA26690555
C006780bisphenol Abisphenol A affects the expression of SSX1 mRNA25181051
D003300Copper[NSC 689534 binds to Copper] which results in increased expression of SSX1 mRNA20971185
C014347decitabinedecitabine affects the expression of SSX1 mRNA18240144
C014347decitabinedecitabine results in increased expression of SSX1 mRNA19401350|2038186
C011890kojic acidkojic acid results in increased expression of SSX1 mRNA16595896
C558013NSC 689534[NSC 689534 binds to Copper] which results in increased expression of SSX1 mRNA20971185
D010662Phenylmercuric Acetate"[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SSX1 mRNA"27188386
D010662Phenylmercuric AcetatePhenylmercuric Acetate results in increased expression of SSX1 mRNA26272509

GO/Pathway

GO ID GO Term Qualifier Evidence PubMed
GO:0003676nucleic acid binding-IEA-  
GO:0003714transcription corepressor activity-TAS10072425  
GO:0005515protein binding-IPI25416956  
GO ID GO Term Qualifier Evidence PubMed
GO:0006351transcription, DNA-templated-IEA-  
GO:0006355regulation of transcription, DNA-templated-IEA-  
GO:1903507negative regulation of nucleic acid-templated transcription-IEA-  
GO ID GO Term Qualifier Evidence PubMed
GO:0005634nucleus-IEA-  
KEGG ID KEGG Term
Reactome ID Reactome Term Evidence

Interactions (STRING v10.5, Interaction Score >= 0.400)

Publications (Co-occurrence of gene symbol strings and ANCO-Dependence terms)

PMID Title (Year) Author Journal
24436244Fine needle aspiration of primary mediastinal synovial sarcoma: cytomorphologic, immunohistochemical, and molecular study. (2014 Feb)Huang CCDiagn Cytopathol